CD274 and gastric neoplasm: A number of T cell co-inhibitory molecules CTLA4, ICOS, CD274, PDCD1, and IDO were markedly downregulated by NPRL2 treatment which was in agreement with the data found in bioinformatics analysis in stomach cancer patients' samples (Pi et al., 2022).